☆ 4.6 Article

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study

Andres Ramos-Fresnedo et al.

Summary: This study aimed to compare the survival outcomes between molecular GBM (molGBM) and histological GBM (histGBM). The results showed that molGBM had a longer progression-free survival (PFS) compared to histGBM, but similar overall survival (OS).

JOURNAL OF NEURO-ONCOLOGY (2022)

Add to Collection

Review Oncology

Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review

Dayton Grogan et al.

Summary: Genetic analyses have identified key molecular features that impact treatment paradigms for gliomas. Some IDH-wildtype infiltrating gliomas behave like higher-grade tumors, despite having lower grade histopathologic appearances. This approach to diagnosis is novel, and more research is needed to understand the exact clinical, radiographic, and histopathologic findings associated with these tumors.

JOURNAL OF NEURO-ONCOLOGY (2022)

Add to Collection

Article Oncology

Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA

Kenan Zhang et al.

Summary: By controlling for molecular subtypes, we found that resection rate and chemotherapy were two prognostic factors associated with survival outcomes in a Chinese cohort with DG.

CANCER BIOLOGY & MEDICINE (2022)

Add to Collection

Review Clinical Neurology

Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

Craig Horbinski et al.

Summary: The fifth edition of the WHO classification of CNS tumours, published in 2021, incorporates major changes in the classification system. This new edition includes more molecular alterations in tumor diagnosis and reorganizes the classification of gliomas and ependymomas. Several new tumor entities, especially pediatric tumors, are added to the 2021 classification. This significant revision will have a major impact on the diagnosis and treatment of CNS tumors.

NATURE REVIEWS NEUROLOGY (2022)

Add to Collection

Review Oncology

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment

Elena Verdugo et al.

Summary: Glioblastoma multiforme (GBM) is a highly aggressive and common primary brain tumor, with recent advances focusing on molecular characterization, heterogeneity, and treatment strategies. Research has delved into molecular parameters for personalized characterization, as well as tumor metabolism, heterogeneity, and potential therapeutic targets including immunotherapy and molecular-targeted therapies.

CANCER COMMUNICATIONS (2022)

Add to Collection

Review Medicine, General & Internal

Molecular pathology and clinical implications of diffuse glioma

Ruichao Chai et al.

Summary: Prognosis for diffusely infiltrating gliomas of WHO grade 2-4 remains poor, but genome-wide molecular-profiling-associated studies have improved classification accuracy. The latest WHO guidelines incorporate molecular biomarkers and histological features for glioma diagnosis. Molecular pathology in clinical practice presents new opportunities for glioma therapy and promotes precision medicine development.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Article

Molecular Pathology of Gliomas

Kristyn Galbraith et al.

Surgical Pathology Clinics (2021)

Add to Collection

Review Oncology

Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review

Dennis Lee et al.

Summary: Patients with DAG-G tend to be older than typical IDH-mutant diffuse astrocytoma patients, have tumors that are more diffuse with focal deficits, and experience significantly shorter overall survival.

JOURNAL OF NEURO-ONCOLOGY (2021)

Add to Collection

Article Clinical Neurology

MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas

C. J. Park et al.

Summary: This study aimed to evaluate whether MR imaging features could identify a subset of IDH wild-type lower-grade gliomas that carry molecular features of glioblastoma. Results showed that a model using both Visually AcceSAble Rembrandt Images and radiomic features had superior predictive performance for determining molecular glioblastoma status.

AMERICAN JOURNAL OF NEURORADIOLOGY (2021)

Add to Collection

Article Clinical Neurology

Molecular Characterization of True Low-Grade IDH-Wild-type Astrocytomas

Timothy E. Richardson et al.

Summary: Recent studies have shown that most IDH-wildtype low-grade astrocytomas have clinical outcomes similar to IDH-wildtype glioblastomas. Despite controversy, a true IDH-wildtype LGA category does exist, with distinct clinical and molecular features including younger age, lower grade, and fewer gene copy number variations.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Morphologic and Molecular Aspects of Glioblastomas

Osorio Lopes Abath Neto et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Add to Collection

Article Oncology

IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification

Giulia Berzero et al.

Summary: The study finds that IDHwt grade II gliomas have a relatively higher survival rate, while patients meeting the definition of molecular glioblastoma have a shorter survival period. The majority of patients meeting the cIMPACT criteria have isolated TERT promoter mutations, which are not significantly associated with poor outcomes.

NEURO-ONCOLOGY (2021)

Add to Collection

Article Oncology

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

C. Mircea S. Tesileanu et al.

NEURO-ONCOLOGY (2020)

Add to Collection

Letter Clinical Neurology

cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV

Daniel J. Brat et al.

ACTA NEUROPATHOLOGICA (2018)

Add to Collection

Review Oncology

Advances in the molecular genetics of gliomas - implications for classification and therapy

Guido Reifenberger et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Add to Collection

Review Oncology

Molecular markers in glioma

Kirsten Ludwig et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Add to Collection

Review Clinical Neurology

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2016)

Add to Collection

Review Oncology

Epidemiologic and Molecular Prognostic Review of Glioblastoma

Jigisha P. Thakkar et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Add to Collection

Article Oncology

Low-Grade Gliomas

Deborah A. Forst et al.

ONCOLOGIST (2014)

Add to Collection

Article

Morphological Characteristics of Brain Tumors Causing Seizures

Jong Woo Lee et al.

ARCHIVES OF NEUROLOGY (2010)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Classification of Brain Tumor Type and Grade Using MRI Texture and Shape in a Machine Learning Scheme

Evangelia I. Zacharaki et al.

MAGNETIC RESONANCE IN MEDICINE (2009)

Add to Collection

Review Clinical Neurology

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

Melanie S. M. van Breemen et al.

LANCET NEUROLOGY (2007)

Add to Collection

Article Clinical Neurology

Seizure disorders in patients with brain tumors

A Liigant et al.

EUROPEAN NEUROLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.